Evidence map›Paper›PMID 39460828›Full record

ArticleBulletin of mathematical biology2024

AMBER: A Modular Model for Tumor Growth, Vasculature and Radiation Response.

Louis V Kunz, Jesús J Bosque, Mohammad Nikmaneshi, Ibrahim Chamseddine, Lance L Munn, Jan Schuemann, Harald Paganetti, Alejandro Bertolet

Abstract read
In one paragraph

Article in Bulletin of mathematical biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Louis V KunzDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
Jesús J BosqueDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
Mohammad NikmaneshiDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
Ibrahim ChamseddineDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
Lance L MunnDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
Jan SchuemannDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
Harald PaganettiDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
Alejandro BertoletDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA. abertoletreina@mgh.harvard.edu.ORCID 0000-0002-9890-693X

Funding

TOPAS - nBio, a Monte Carlo tool for radiation biology researchR01CA187003 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI SCHUEMANN, JAN PATRICK OSCAR · 2015 to 2024
$4.8M
Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistanceU01CA261842 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI JAIN, RAKESH K., MUNN, LANCE L. · 2021 to 2025
$3.1M
Developing whole-body computational phantoms for blood dosimetry to model the impact of radiation on the immune systemR01CA248901 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI BOLCH, WESLEY E, PAGANETTI, HARALD · 2020 to 2024
$2.4M
Targeting glycocalyx-mediated mechanisms of tumor metastasisR01CA204949 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI MUNN, LANCE L., TARBELL, JOHN M · 2017 to 2021
$2.3M
Radiation dosimetry for alpha-particle radiopharmaceutical therapy and application to pediatric neuroblastomaR00CA267560 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI BERTOLET REINA, ALEJANDRO · 2023 to 2025
$721k
Dubai Harvard Foundation for Medical Research Prince Alwaleed Bin Talal Research FellowshipNCI NIH HHS R00 CA267560NCI NIH HHS R00CA267560NCI NIH HHS R01 CA187003NCI NIH HHS R01CA187003NCI NIH HHS R01 CA204949NCI NIH HHS R01CA204949NCI NIH HHS R01 CA248901NCI NIH HHS R01CA248901NCI NIH HHS U01 CA261842NCI NIH HHS U01CA261842
6 · The paper itself

Abstract

Computational models of tumor growth are valuable for simulating the dynamics of cancer progression and treatment responses. In particular, agent-based models (ABMs) tracking individual agents and their interactions are useful for their flexibility and ability to model complex behaviors. However, ABMs have often been confined to small domains or, when scaled up, have neglected crucial aspects like vasculature. Additionally, the integration into tumor ABMs of precise radiation dose calculations using gold-standard Monte Carlo (MC) methods, crucial in contemporary radiotherapy, has been lacking. Here, we introduce AMBER, an Agent-based fraMework for radioBiological Effects in Radiotherapy that computationally models tumor growth and radiation responses. AMBER is based on a voxelized geometry, enabling realistic simulations at relevant pre-clinical scales by tracking temporally discrete states stepwise. Its hybrid approach, combining traditional ABM techniques with continuous spatiotemporal fields of key microenvironmental factors such as oxygen and vascular endothelial growth factor, facilitates the generation of realistic tortuous vascular trees. Moreover, AMBER is integrated with TOPAS, an MC-based particle transport algorithm that simulates heterogeneous radiation doses. The impact of radiation on tumor dynamics considers the microenvironmental factors that alter radiosensitivity, such as oxygen availability, providing a full coupling between the biological and physical aspects. Our results show that simulations with AMBER yield accurate tumor evolution and radiation treatment outcomes, consistent with established volumetric growth laws and radiobiological understanding. Thus, AMBER emerges as a promising tool for replicating essential features of tumor growth and radiation response, offering a modular design for future expansions to incorporate specific biological traits.

Indexed as

AlgorithmsComputer SimulationMathematical ConceptsModels, BiologicalMonte Carlo MethodNeoplasmsNeovascularization, PathologicTumor MicroenvironmentAnimalsHumansVascular Endothelial Growth Factor AVascular Endothelial Growth Factor AAgent-based modelsHybrid modelsRadiation responseTumor modelingTumor vascular modeling

Identifiers

PMID39460828
PMCPMC12129000

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.